The Cooper Companies has completed its acquisition of Sauflon Pharmaceuticals for approximately $1.2bn.
It said the investment gave CooperVision the ability to offer the world’s most extensive range of daily disposable contact lens options.
‘We’re approaching the daily disposables category with a new, multi-tier model. By adding the Sauflon portfolio to our already-strong MyDay and Proclear brand choices, we’re bringing forward multiple contact lens families designed and marketed for distinct wearer segments,’ said Daniel McBride, president of CooperVision.
‘This approach to the market provides practitioners the ability to offer a daily disposable lens for every eye and every budget, which should further accelerate both practice growth and category momentum.’
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here